Monoclonal antibodies for the treatment of Ebola virus disease

Moekotte, A. L.; Huson, M. A. M.; van der Ende, A. J.; Agnandji, S. T.; Huizenga, E.; Goorhuis, A.; Grobusch, M. P.

dc.contributor.author	Agnandji, Selidji Todagbe
dc.contributor.author	Grobusch, Martin
dc.date.accessioned	2018-08-28T09:50:43Z
dc.date.available	2018-08-28T09:50:43Z
dc.date.issued	2016
dc.identifier.issn	1744-7658
dc.identifier.uri	http://hdl.handle.net/10900/83859
dc.language.iso	en	de_DE
dc.publisher	Taylor & Francis Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1080/13543784.2016.1240785	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Monoclonal antibodies for the treatment of Ebola virus disease	de_DE
dc.type	Article	de_DE
utue.quellen.id	20180405102126_00600
utue.publikation.seiten	1325-1335	de_DE
utue.personen.roh	Moekotte, A. L.
utue.personen.roh	Huson, M. A. M.
utue.personen.roh	van der Ende, A. J.
utue.personen.roh	Agnandji, S. T.
utue.personen.roh	Huizenga, E.
utue.personen.roh	Goorhuis, A.
utue.personen.roh	Grobusch, M. P.
dcterms.isPartOf.ZSTitelID	Expert Opinion on Investigational Drugs	de_DE
dcterms.isPartOf.ZS-Issue	11	de_DE
dcterms.isPartOf.ZS-Volume	25	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE